Treatment of lung cancer
288 results
201 - 288Cannabis‐based medicines and medical cannabis for adults with cancer pain
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
Mindfulness‐based stress reduction for women diagnosed with breast cancer
Alcoholic liver disease (ALD)
Myositis
Population screening for cancer
PET‐CT for assessing mediastinal lymph node involvement in patients with suspected resectable non‐small cell lung cancer
Infections in immunocompromized children
Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
High‐dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents, and young adults with primary metastatic Ewing sarcoma
Topical tretinoin may increase all-cause mortality
Pneumonia
Deep vein thrombosis
Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)
Golimumab for rheumatoid arthritis
Interventions for fatigue and weight loss in adults with advanced progressive illness
Genetic test results that identify increased risk do not change behavior
Antifibrinolytic therapy to reduce haemoptysis from any cause
Fluorine‐18‐fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma
PSA for screening of prostate cancer
Lymphomas
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases
Targeted therapy for advanced renal cell carcinoma
Antitubercular medication in ambulatory care
Unintentional weight loss in adults
Interventions for preventing neuropathy caused by cisplatin and related compounds
Telephone interventions for symptom management in adults with cancer
Chemotherapy for advanced non‐small cell lung cancer in the elderly population
Radiotherapy and surgery in early breast cancer
Chronic obstructive pulmonary disease (COPD)
Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances
Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease
Screening for prostate cancer
Baricitinib is effective for severe alopecia areata, but long-term safety is not known
Glucocorticoid with cyclophosphamide for oral paraquat poisoning
Single or combined immune checkpoint inhibitors compared to first‐line platinum‐based chemotherapy with or without bevacizumab for people with advanced non‐small cell lung cancer
Interventions for promoting habitual exercise in people living with and beyond cancer
Galactomannan detection in broncho‐alveolar lavage fluid for invasive aspergillosis in immunocompromised patients
Systematic screening and assessment of psychosocial well‐being and care needs of people with cancer
Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long‐term condition: a mixed methods review
Early palliative care for adults with advanced cancer
Palliative treatment
Male hypogonadism and hormone replacement
Neuromuscular electrical stimulation for the prevention of venous thromboembolism
Chemotherapy for advanced gastric cancer
Golimumab for rheumatoid arthritis: Cochrane systematic review
Treatment for Lambert‐Eaton myasthenic syndrome
Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy
Intravenous remdesivir for 3 days reduces hospitalization in outpatients with symptomatic COVID-19
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
Exercise for cancer cachexia in adults
Dehydroepiandrosterone for systemic lupus erythematosus
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
Positioning and spinal bracing for pain relief in metastatic spinal cord compression in adults
Superficial venous thrombophlebitis
Methods to decrease blood loss during liver resection: a network meta‐analysis
Antioxidant vitamin and mineral supplements for preventing age‐related macular degeneration
Long‐term hormone therapy for perimenopausal and postmenopausal women
Percutaneous ethanol injection for liver metastases
Metabolic syndrome
Ambient air pollution
Radical multimodality therapy for malignant pleural mesothelioma
Exercise interventions for adults after liver transplantation
Systemic treatments for metastatic cutaneous melanoma
Differences in the effectiveness of individual‐level smoking cessation interventions by socioeconomic status
Hypertension: investigations, treatment initiation and non-pharmacological treatment
Interventions for smoking cessation in hospitalised patients
Graduated compression stockings for prevention of deep vein thrombosis
Interventions for tobacco cessation delivered by dental professionals
Anti‐epidermal growth factor receptor therapy for glioblastoma in adults
Rare endocrine tumours
Vaccines for preventing infections in adults with solid tumours
Chronic diseases and pregnancy
Perioperative alcohol cessation intervention for postoperative complications
Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism
Interventions for the management of malignant pleural effusions: a network meta‐analysis